CTL ePBMC (cryopreserved Peripheral Blood Mononuclear Cells) provide researchers with access to a comprehensive donor library of 400+ individuals, offering a highly reliable and standardized solution for immunological studies. Each donor sample is cryopreserved to maintain full cellular functionality, with hundreds of aliquots available per subject—allowing experiments to be repeated, validated, and expanded over time with consistency.
These ePBMC are extensively characterized for T-cell and B-cell reactivity against a wide range of clinically relevant antigens, including SARS-CoV-2, HCMV, EBV, influenza, and other common recall antigens. This makes them an invaluable resource for ELISPOT and FluoroSpot assay development, validation, and proficiency testing.
The availability of HLA-typed donor cohorts further enhances research capabilities, enabling scientists to select samples based on specific allele requirements. With dozens of donors available for most alleles, researchers can quickly access suitable cohorts without the complexity of donor recruitment.
CTL’s ePBMC platform eliminates many logistical and regulatory challenges—no IRB approval is required for many applications, and ready-to-use samples accelerate research timelines. These cells support complete study execution, from assay optimization to large-scale validation, making them ideal for immunology research, vaccine development, and cell-based assays.
With their combination of consistency, availability, and biological relevance, CTL ePBMC serve as a powerful tool for advancing immunological research and ensuring reproducible scientific outcomes.
Labindia Instruments Pvt. Ltd. is the authorised dealer in India for CTL (Cellular Technology Limited), providing trusted solutions and expert technical support.
